Madrigal Pharmaceuticals Gets First FDA Approval for Drug Targeting Liver Disease MASH
Madrigal Pharmaceuticals Gets First FDA Approval for Drug Targeting Liver Disease MASH
Madrigal Pharmicals 首次獲得 FDA 批准的針對肝臟疾病的藥物 MASH
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊